Covered recipient · General Payments record
PAUL D MULLIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$150,198.40
- Reported across 603 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $545.14 | 8 |
| Education | $73.96 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LivaNova USA, Inc. | $164.54 | 2 |
| Neurelis, Inc. | $133.50 | 2 |
| EISAI INC. | $95.20 | 1 |
| SK Life Science, Inc. | $84.82 | 1 |
| Teva Pharmaceuticals USA, Inc. | $82.80 | 2 |
| Ceribell, Inc. | $44.41 | 1 |
| Lilly USA, LLC | $13.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ceribell, Inc. | $44.41 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153956017 | CMS |
| Eisai Inc. | $95.20 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110772097 | CMS |
| Lilly USA, LLC | $13.83 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135268333 | CMS |
| LivaNova USA, Inc. | $150.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152786299 | CMS |
| LivaNova USA, Inc. | $14.54 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152786369 | CMS |
| Neurelis, Inc. | $12.96 | 05/15/2024 | Education | Undisputed | 01/23/2026 | 1145648930 | CMS |
| Neurelis, Inc. | $120.54 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648932 | CMS |
| SK Life Science, Inc. | $84.82 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154110729 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.80 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151488861 | CMS |
| Teva Pharmaceuticals USA, Inc. | $61.00 | 05/15/2024 | Education | Undisputed | 01/23/2026 | 1151488941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.